These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3226339)

  • 1. A comparison of the effects of ethinyl estradiol and estradiol valerate on serum and lipoprotein lipids.
    Lindberg UB; Enk L; Crona N; Silfverstolpe G
    Maturitas; 1988 Dec; 10(4):343-52. PubMed ID: 3226339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid metabolic studies in oophorectomized women: effects induced by two different estrogens on serum lipids and lipoproteins.
    Silfverstolpe G; Gustafson A; Samsioe G; Svanborg A
    Gynecol Obstet Invest; 1980; 11(3):161-9. PubMed ID: 7439809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins.
    März W; Gross W; Gahn G; Romberg G; Taubert HD; Kuhl H
    Am J Obstet Gynecol; 1985 Oct; 153(3):287-93. PubMed ID: 2931988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose and duration effects of estradiol valerate on serum and lipoprotein lipids.
    Enk L; Crona N; Samsioe G; Silfverstolpe G
    Horm Metab Res; 1986 Aug; 18(8):551-4. PubMed ID: 3530933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
    Wiegratz I; Jung-Hoffmann C; Gross W; Kuhl H
    Contraception; 1998 Aug; 58(2):83-91. PubMed ID: 9773262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of two gonane progestins alone and in combination with ethinyl estradiol on serum lipoproteins.
    Crona N; Silfverstolpe G; Samsioe G
    Eur J Obstet Gynecol Reprod Biol; 1985 Jun; 19(6):365-74. PubMed ID: 3160616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
    Akerlund M; Almström E; Högstedt S; Nabrink M
    Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cyproterone acetate (CPA) on serum lipoproteins when administered alone and in combination with ethinyl estradiol (EE).
    Lindberg UB; Crona N; Enk L; Samsioe G; Silfverstolpe G
    Horm Metab Res; 1987 May; 19(5):222-5. PubMed ID: 2953663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
    Oyelola OO
    Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol.
    Goebelsmann U; Mashchak CA; Mishell DR
    Am J Obstet Gynecol; 1985 Apr; 151(7):868-77. PubMed ID: 3920910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
    Prasad RN; Liew D; Ratnam SS
    Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid metabolic studies in women with a polycystic ovary syndrome during treatment with a low-dose desogestrel-ethinylestradiol combination.
    Cullberg G; Hamberger L; Mattsson LA; Mobacken H; Samsioe G
    Acta Obstet Gynecol Scand; 1985; 64(3):203-7. PubMed ID: 3160212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
    Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R
    Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid and biochemical changes after low-dose oral contraception.
    Loke DF; Ng CS; Holck S; Hall PE; Ratnam SS
    Contraception; 1992 Sep; 46(3):227-41. PubMed ID: 1451519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on lipids and lipoproteins in women treated with oestradiol and progesterone.
    Darj E; Crona N; Nilsson S
    Maturitas; 1992 Dec; 15(3):209-15. PubMed ID: 1465034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.